Learn More
For those interested in learning more about universal pharmacare, we have provided links to reports by our network of experts, government commissions and panels, and public interest groups. We have selected these as credible sources of information concerning the rationale for universal pharmacare, public opinion concerning universal pharmacare, and the cost of universal pharmacare.
Pharmacare 2020’s recommendations
2015 final report of Pharmacare 2020’s study and consultations concerning pharmacare options for Canada: “Pharmacare 2020: The Future of Drug Coverage in Canada”
Government commissions recommending universal, public pharmacare
1964 final report of the Royal Commission on Health Services (Hall Commission)
1997 final report of the National Forum on Health
2002 final report of the Royal Commission on the Future of Health Care in Canada (Romanow Commission)
2018 final report on pharmacare by the all-party Parliamentary Standing Committee on Health
2019 final report of the Advisory Council on the Implementation of National Pharmacare
Studies and statements of public opinion
2016 Necessary Medicines: Recommendations of the Citizens’ Reference Panel on Pharmacare in Canada
2019 Consensus Principles for Universal Pharmacare developed and endorsed by dozens of groups representing public interests, labour unions, and health professionals.
2020 Angus Reid Institute study, Access for all: Near universal support for a pharmacare plan covering Canadians’ prescription drug costs.
Studies of the cost of universal pharmacare
2010 CCPA, IRIS study, The Economic Case for Universal Pharmacare
2015 CMAJ article, Estimated cost of universal public coverage of prescription drugs in Canada
2017 CMAJ article, Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada
2017 Parliamentary Budget Officer’s report, The Federal Cost of a National Pharmacare Program
2019 final report of the Advisory Council on the Implementation of National Pharmacare